オメプラゾール、オメプラゾールナトリウム
WordNet
- a silvery soft waxy metallic element of the alkali metal group; occurs abundantly in natural compounds (especially in salt water); burns with a yellow flame and reacts violently in water; occurs in sea water and in the mineral halite (rock salt) (同)Na, atomic number 11
- antacid (trade name Prilosec) that suppresses acid secretion in the stomach (同)Prilosec
PrepTutorEJDIC
- ソジウム,ナトリウム(金属元素;化学記号はNa)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Related Substances of Ketoprofen and Omeprazole in Combined Capsule Dosage Form.
- Koppala S1, Ranga Reddy V2, Anireddy JS3.
- Journal of chromatographic science.J Chromatogr Sci.2016 May;54(5):765-75. doi: 10.1093/chromsci/bmw008. Epub 2016 Feb 8.
- A novel, simple, sensitive, selective and reproducible stability-indicating high performance liquid chromatographic method was developed for the quantitative determination of degradation products and process-related impurities of ketoprofen (KET) and omeprazole (OMZ) in combined oral solid dosage fo
- PMID 26860397
- Adverse Geriatric Outcomes Secondary to Polypharmacy in a Mouse Model: The Influence of Aging.
- Huizer-Pajkos A1, Kane AE2, Howlett SE3, Mach J2, Mitchell SJ4, de Cabo R4, Le Couteur DG5, Hilmer SN6.
- The journals of gerontology. Series A, Biological sciences and medical sciences.J Gerontol A Biol Sci Med Sci.2016 May;71(5):571-7. doi: 10.1093/gerona/glv046. Epub 2015 May 4.
- We aimed to develop a mouse model of polypharmacy, primarily to establish whether short-term exposure to polypharmacy causes adverse geriatric outcomes. We also investigated whether old age increased susceptibility to any adverse geriatric outcomes of polypharmacy. Young (n= 10) and old (n= 21) male
- PMID 25940962
- Gastroprotective activity of chloroform extract of Muntingia calabura and Melastoma malabathricum leaves.
- Zakaria ZA1,2,3, Zainol AS3, Sahmat A3, Salleh NI3, Hizami A3, Mahmood ND3, Nasir N3, Mamat SS3, Kamisan FH3, Mohtarrudin N4, Abdul Hamid SS5, Tohid SF1, Teh LK2, Salleh MZ2.
- Pharmaceutical biology.Pharm Biol.2016 May;54(5):812-26. doi: 10.3109/13880209.2015.1085580. Epub 2015 Oct 9.
- CONTEXT: Muntingia calabura L. (family Muntingiaceae) and Melastoma malabathricum L. (family Melastomaceae) are traditionally used to treat gastric ulcer.OBJECTIVE: The present study determines the mechanisms of gastroprotective activity of the chloroform extract of leaves obtained from both the pla
- PMID 26452435
Japanese Journal
- Effect of long-term proton pump inhibitor therapy and healing effect of irsogladine on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions in healthy volunteers
- Kojima Yuichi,Takeuchi Toshihisa,Ota Kazuhiro,Harada Satoshi,Edogawa Shoko,Narabayashi Ken,Nouda Sadaharu,Okada Toshihiko,Kakimoto Kazuki,Kuramoto Takanori,Inoue Takuya,Higuchi Kazuhide
- Journal of Clinical Biochemistry and Nutrition 57(1), 60-65, 2015
- … This study assessed time-course changes of the small intestinal lesions during long-term treatment with diclofenac sodium plus omeprazole and the effects of irsogladine on such lesions. … Thirty two healthy volunteers were treated with diclofenac sodium (75 mg/day) plus omeprazole (10 mg/day) for 6 weeks, with irsogladine (4 mg/day) added from weeks 6 to 10 (Group A) or with diclofenac sodium plus irsogladine for 6 weeks (Group B). …
- NAID 130005085263
- Effect of long-term proton pump inhibitor therapy and healing effect of irsogladine on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions in healthy volunteers
- Kojima Yuichi,Takeuchi Toshihisa,Ota Kazuhiro,Harada Satoshi,Edogawa Shoko,Narabayashi Ken,Nouda Sadaharu,Okada Toshihiko,Kakimoto Kazuki,Kuramoto Takanori,Inoue Takuya,Higuchi Kazuhide
- Journal of Clinical Biochemistry and Nutrition advpub(0), 2015
- … This study assessed time-course changes of the small intestinal lesions during long-term treatment with diclofenac sodium plus omeprazole and the effects of irsogladine on such lesions. … Thirty two healthy volunteers were treated with diclofenac sodium (75 mg/day) plus omeprazole (10 mg/day) for 6 weeks, with irsogladine (4 mg/day) added from weeks 6 to 10 (Group A) or with diclofenac sodium plus irsogladine for 6 weeks (Group B). …
- NAID 130005078151
- 大塚 恭寛
- 日本腹部救急医学会雑誌 = Journal of abdominal emergency medicine 32(5), 967-971, 2012-07-31
- 症例はアルコール性肝硬変(Child-Pugh分類Grade C)を有する62歳男性で,嘔吐に続く呼吸苦を主訴に嘔吐4時間後に当院を救急受診。食道造影にて下部食道右側壁に径1cmの破裂部を認め,右胸腔内穿破型の特発性食道破裂と診断。基礎疾患の重症度を考慮し,右胸腔穿刺ドレナージ・破裂部口側への経鼻的減圧チューブ挿入・中心静脈栄養管理・オメプラゾールと抗菌薬投与による保存的治療を選択した。第2病日に …
- NAID 10031165278
Related Links
- ChemicalBook あなたのためにOmeprazole sodium(95510-70-6)の化学的性質を提供して、融点、価格、蒸気圧、沸点、毒性、比重、沸点、密度、分子式、分子量、物理的な性質、毒性 税関のコードなどの情報、同時にあなたは更に ...
- Omeprazole Sodium Manufacturers in India Suppliers Omeprazole Sodium Exporters Distributors Omeprazole Sodium api active pharmaceuticals ingredients Omeprazole Sodium manufacturers Side Effects bulk drugs raw material Omeprazole Sodium companies ...
★リンクテーブル★
[★]
- 英
- omeprazole
- 化
- オメプラゾールナトリウム omeprazole sodium
- 商
- エンプラール、オブランゼ、オメプトロール、オメプラール、オメプラゾン、オメプロトン、オメラップ, Prilosec
- 関
- プロトンポンプ阻害薬
分類
-
適応
相互作用
併用禁忌
副作用